Air Canada Cargo today announced that it has become a member of the Pharma.Aero cross-industry collaboration platform. Working with other key stakeholders in the pharmaceutical transportation sector, Air Canada Cargo will contribute to and benefit from the group’s knowledge and expertise to further develop its handling of pharmaceutical shipments.
“As we continue to expand our freighter fleet and with the continued enhancements to our cold chain handling capabilities, this participation in a new avenue for critical insight into pharmaceutical shipments is an important step forward. Pharma.Aero will increase our ability to collaborate with an ever-growing list of industry experts to share ideas and gather knowledge on ways to further strengthen our expertise in shipping this vital cargo,” said Matthieu Casey, Managing Director – Commercial at Air Canada Cargo.
“We are extremely pleased to welcome Air Canada Cargo to our Pharma.Aero global community. As a Canadian, and as a Chairman of Pharma.Aero, I am proud to see Canada enlarging its footprint in our organization, as it is one of the leading countries in Life Science manufacturing. It is our vision and mission, as a cross-industry organization, to have a strong presence on all continents, especially in North America, to get different perspectives of our industry and to offer worldwide visibility to our new members and partners,” said Trevor Caswell, Chairman of Pharma.Aero Board of Directors.
In addition to the cold chain facility, Air Canada Cargo also utilizes an extensive list of industry recognized active containers, including live-monitored, temperature-controlled certified aircraft containers, like the Envirotainer Releye RLP and larger RAP, as part of the AC Absolute solution.
